Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 9
February 28 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

TRANSFUSION MEDICINE
Cold agglutinins: fending off the attack
Sigbjørn Berentsen
View Articletitled, Cold agglutinins: fending off the attack
CLINICAL TRIALS AND OBSERVATIONS
Refining CNS relapse risk in DLBCL: easy as ABC?
Clinical Trials & Observations
Christopher P. Fox
View Articletitled, Refining CNS relapse risk in DLBCL: easy as ABC?
Lymphoid Neoplasia
Three targets in 1 shot against ibrutinib resistance
David Chiron
View Articletitled, Three targets in 1 shot against ibrutinib resistance
Lymphoid Neoplasia
A new Burkitt “look-alike” lymphoma
Mitchell S. Cairo
View Articletitled, A new Burkitt “look-alike” lymphoma
THROMBOSIS AND HEMOSTASIS
Fibronectin: a “double hit” modulator in HIT?
Yves Gruel,Jerome Rollin
View Articletitled, Fibronectin: a “double hit” modulator in HIT?

PLENARY PAPER

TRANSFUSION MEDICINE
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Clinical Trials & Observations
Ulrich Jäger,Shirley D’Sa,Christian Schörgenhofer,Johann Bartko,Ulla Derhaschnig,Christian Sillaber,Petra Jilma-Stohlawetz,Michael Fillitz,Thomas Schenk,Gary Patou,Sandip Panicker,Graham C. Parry,James C. Gilbert,Bernd Jilma
View Articletitled, Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Supplemental data

BLOOD SPOTLIGHT

Bad weed: synthetic cannabinoid–associated coagulopathy
Gowthami M. Arepally,Thomas L. Ortel
View Articletitled, Bad weed: synthetic cannabinoid–associated coagulopathy

REVIEW ARTICLE

Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
Shaun P. Jackson,Roxane Darbousset,Simone M. Schoenwaelder
View Articletitled, Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms

CLINICAL TRIALS AND OBSERVATIONS

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
Clinical Trials & Observations
Magdalena Klanova,Laurie H. Sehn,Isabelle Bence-Bruckler,Federica Cavallo,Jie Jin,Maurizio Martelli,Douglas Stewart,Umberto Vitolo,Francesco Zaja,Qingyuan Zhang,Federico Mattiello,Gila Sellam,Elizabeth A. Punnoose,Edith Szafer-Glusman,Christopher R. Bolen,Mikkel Z. Oestergaard,Guenter R. Fingerle-Rowson,Tina Nielsen,Marek Trneny
View Articletitled, Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
Supplemental data

HEMATOPOIESIS AND STEM CELLS

A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data
David J. H. F. Knapp,Colin A. Hammond,Fangwu Wang,Nima Aghaeepour,Paul H. Miller,Philip A. Beer,Davide Pellacani,Michael VanInsberghe,Carl Hansen,Sean C. Bendall,Garry P. Nolan,Connie J. Eaves
View Articletitled, A topological view of human CD34<sup>+</sup> cell state trajectories from integrated single-cell output and proteomic data
Supplemental data

LYMPHOID NEOPLASIA

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
David Martín-Garcia,Alba Navarro,Rafael Valdés-Mas,Guillem Clot,Jesús Gutiérrez-Abril,Miriam Prieto,Inmaculada Ribera-Cortada,Renata Woroniecka,Grzegorz Rymkiewicz,Susanne Bens,Laurence de Leval,Andreas Rosenwald,Judith A. Ferry,Eric D. Hsi,Kai Fu,Jan Delabie,Dennis Weisenburger,Daphne de Jong,Fina Climent,Sheila J. O’Connor,Steven H. Swerdlow,David Torrents,Sergi Beltran,Blanca Espinet,Blanca González-Farré,Luis Veloza,Dolors Costa,Estella Matutes,Reiner Siebert,German Ott,Leticia Quintanilla-Martinez,Elaine S. Jaffe,Carlos López-Otín,Itziar Salaverria,Xose S. Puente,Elias Campo,Sílvia Beà
View Articletitled, <em>CCND2</em> and <em>CCND3</em> hijack immunoglobulin light-chain enhancers in cyclin D1<sup>−</sup> mantle cell lymphoma
Supplemental data
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
Dennis Dobrovolsky,Eric S. Wang,Sara Morrow,Catharine Leahy,Tyler Faust,Radosław P. Nowak,Katherine A. Donovan,Guang Yang,Zhengnian Li,Eric S. Fischer,Steven P. Treon,David M. Weinstock,Nathanael S. Gray
View Articletitled, Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
Supplemental data
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Brief Report
Rabea Wagener,Julian Seufert,Francesco Raimondi,Susanne Bens,Kortine Kleinheinz,Inga Nagel,Janine Altmüller,Holger Thiele,Daniel Hübschmann,Christian W. Kohler,Peter Nürnberg,Rex Au-Yeung,Birgit Burkhardt,Heike Horn,Lorenzo Leoncini,Elaine S. Jaffe,German Ott,Grzegorz Rymkiewicz,Matthias Schlesner,Robert B. Russell,Wolfram Klapper,Reiner Siebert
View Articletitled, The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Supplemental data

THROMBOSIS AND HEMOSTASIS

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
Paul S. de Vries,Maria Sabater-Lleal,Jennifer E. Huffman,Jonathan Marten,Ci Song,Nathan Pankratz,Traci M. Bartz,Hugoline G. de Haan,Graciela E. Delgado,John D. Eicher,Angel Martinez-Perez,Cavin K. Ward-Caviness,Jennifer A. Brody,Ming-Huei Chen,Moniek P. M. de Maat,Mattias Frånberg,Dipender Gill,Marcus E. Kleber,Fernando Rivadeneira,José Manuel Soria,Weihong Tang,Geoffrey H. Tofler,André G. Uitterlinden,Astrid van Hylckama Vlieg,Sudha Seshadri,Eric Boerwinkle,Neil M. Davies,Anne-Katrin Giese,M. Kamran Ikram,Steven J. Kittner,Barbara McKnight,Bruce M. Psaty,Alex P. Reiner,Muralidharan Sargurupremraj,Kent D. Taylor,INVENT Consortium,MEGASTROKE Consortium of the International Stroke Genetics Consortium,Myriam Fornage,Anders Hamsten,Winfried März,Frits R. Rosendaal,Juan Carlos Souto,Abbas Dehghan,Andrew D. Johnson,Alanna C. Morrison,Christopher J. O'Donnell,Nicholas L. Smith
View Articletitled, A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
Supplemental data
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT
Krystin Krauel,Patricia Preuße,Theodore E. Warkentin,Catja Trabhardt,Sven Brandt,Inga Jensch,Martin Mandelkow,Elke Hammer,Sven Hammerschmidt,Andreas Greinacher
View Articletitled, Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT
Supplemental data

LETTERS TO BLOOD

Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL
Clinical Trials & Observations
Jennifer R. Brown,Susan O’Brien,C. Daniel Kingsley,Herbert Eradat,John M. Pagel,Jamie Hirata,Tammy McIver,Rodica Morariu-Zamfir,Thomas J. Kipps
View Articletitled, Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL
Development of a virtual benign hematology consultation service: results of a pilot project involving 5 medical centers
Clinical Trials & Observations
Ashok Pai,Dinesh Kotak,Nancy Facher,Kyle Reader,Kevin Kong,Tatjana Kolevska
View Articletitled, Development of a virtual benign hematology consultation service: results of a pilot project involving 5 medical centers
Low-dose rituximab in autoimmune hemolytic anemia: 10 years after
Bruno Fattizzo,Anna Zaninoni,Loredana Pettine,Francesca Cavallaro,Eros Di Bona,Wilma Barcellini
View Articletitled, Low-dose rituximab in autoimmune hemolytic anemia: 10 years after

BLOOD WORK

Severe mosquito bite allergy: an unusual EBV+ NK cell lymphoproliferative disorder
Jonathan Said,Chandra Smart
View Articletitled, Severe mosquito bite allergy: an unusual EBV<sup>+</sup> NK cell lymphoproliferative disorder
Transient appearance of ring sideroblasts in peripheral blood in the acute phase of secondary hemolytic anemia
Fei Wang,Geng Wang
View Articletitled, Transient appearance of ring sideroblasts in peripheral blood in the acute phase of secondary hemolytic anemia
All Issues

Advertisement intended for health care professionals

Ferroptosis regulates hemolysis in stored murine and human red blood cells
Approaching a therapeutic inflection point for FLT3-mutated AML
How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms
Imetelstat: A new addition to the Therapeutic Landscape of Lower-Risk MDS
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals